DGX vs IOSP · P/E 22, rev $5.94B vs P/E 18, rev $491.4M
Quest Diagnostics Incorporated (DGX) versus Innospec Inc (IOSP) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Innospec Inc (IOSP) is a specialty chemicals company listed on NASDAQ.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported IOSP revenue for 2026-06-30 was $491.4M. Net income was $30.8M. Revenue was up 8.4% from 2026-03-31 to 2026-06-30. IOSP currently screens at market cap $2.05B and trailing P/E 18.1.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. IOSP currently screens at market cap $2.05B and trailing P/E 18.1.
Not investment advice. Open the DGX and IOSP stock pages for the full models.
Not investment advice.